{
    "clinical_study": {
        "@rank": "90587", 
        "acronym": "KTBIS", 
        "arm_group": [
            {
                "arm_group_label": "Single (no catheter)", 
                "arm_group_type": "No Intervention", 
                "description": "ropivacaine single injection : 5 mg/ml 15 ml"
            }, 
            {
                "arm_group_label": "Continuous infusion", 
                "arm_group_type": "Experimental", 
                "description": "Single injection with continuous injection ropivacaine 2 mg/ml 8 ml/h"
            }
        ], 
        "brief_summary": {
            "textblock": "Interscalene block with local anesthetic impairs ventilation (unilateral diaphragmatic\n      dysfunction). Single injection of local anesthetic induced transitory dysfunction (< 24h).\n      The investigators hypothesized that continuous interscalene block would prolonged\n      ventilatory impairment"
        }, 
        "brief_title": "Effect of Interscalene Block on Ventilatory Function", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Respiratory Depression", 
            "Anesthesia Morbidity", 
            "Block"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Respiratory Insufficiency"
            ]
        }, 
        "detailed_description": {
            "textblock": "Unilateral pulmonary dysfunction occured after interscalene block due to phrenic nerve\n      paralysis. This reduction induced vital capacity alteration and peek flow reduction.Several\n      studies analysed dysfunction recovery duration after single injection using short\n      (lidocaine)or intermediate (ropivacaine, bupivacaine)local anesthetic drug. Because\n      continuous infusion prolonged block duration, phenic nerve may be also prolonged. However no\n      study with continuous interscalene infusion have been performed for this dysfunction."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  surgery : scheduled for elective shoulder surgery\n\n          -  available for 1 month of follow up\n\n          -  physical status : 1, 2, 3\n\n        Exclusion Criteria:\n\n          -  body mass index > 35\n\n          -  contraindication for interscalene block (local sepsis, bleeding, allergy, peripheral\n             neuropathy)\n\n          -  vital capacity less than 1.5 liters\n\n          -  cardiac or renal insufficiency\n\n          -  physical status >3, pregnant, weigh less than 50 kg"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "70", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 26, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01740453", 
            "org_study_id": "KTBIS-2012-V1"
        }, 
        "intervention": {
            "arm_group_label": "Continuous infusion", 
            "description": "single", 
            "intervention_name": "ropivacaine 2 mg/ml", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 21, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "state": "Ile de France", 
                    "zip": "75013"
                }, 
                "name": "Centre hospitalier La Piti\u00e9 Salpetriere"
            }
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Interscalene Block on Ventilatory Function After Shoulder Surgery : Evaluation of Single or Continuous Injection", 
        "other_outcome": {
            "description": "outcome measure was performed using a cold test on the skin", 
            "measure": "Duration of sensory interscalene block", 
            "safety_issue": "No", 
            "time_frame": "Day 2"
        }, 
        "overall_official": {
            "affiliation": "Caremeau Hospital, Nimes, France", 
            "last_name": "Philippe Cuvillon, Md,PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "A 25 % reduction of the pulmonary forced vital capacity is expected and measured using spirometer", 
            "measure": "Reduction of the pulmonary forced vital capacity", 
            "safety_issue": "No", 
            "time_frame": "Day  2"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01740453"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Centre Hospitalier Universitaire de N\u012bmes", 
            "investigator_full_name": "Philippe Cuvillon", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Outcome measure was performed using a spirometer", 
                "measure": "Reduction of the pulmonary maximum forced expiratory flow", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "description": "Additional morphine administration for pain management (morphine intravenous : 1 mg every 7 min when necessary,  pain score > 3/10)", 
                "measure": "Morphine consumption", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }, 
            {
                "description": "Outcome Measure using a visual analog scale (0 to 10)", 
                "measure": "Pain score at rest and motion", 
                "safety_issue": "No", 
                "time_frame": "Day 2"
            }
        ], 
        "source": "Pierre and Marie Curie University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pierre and Marie Curie University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}